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Introduction
During exercise, especially in a hot environment, the evaporation of sweat from the skin is the primary mechanism through which heat loss occurs. Nitric oxide (NO) is an important modulator of the sweating response during moderate-intensity exercise [ß40% peak rate of oxygen uptake (V O 2 peak ); Fujii et al. 2014b] . However, NO-dependent sweating is absent during exercise at higher intensities (ß70%V O 2 peak ; Fujii et al. 2014b) . High-intensity exercise is associated with an accumulation of reactive oxygen species (ROS), such as superoxide, which may overwhelm endogenous antioxidant capacity, leading to oxidative stress. Indeed, circulating malondialdehyde (an oxidative stress marker) remains elevated after 30 min of high-(75%V O 2 peak ) but not moderate-intensity cycling (50%V O 2 peak ; Goto et al. 2003) . Ambient heat stress may exacerbate this response, as evidenced by greater increases in malondialdehyde after intense exercise (ࣙ75%V O 2 peak ) in a hot (ß32°C) relative to cool (ß12°C) environment (Sureda et al. 2015) . Accumulated ROS can react with NO, reducing its bioavailability (Radi et al. 1991; Mortensen & Lykkesfeldt, 2014) and thereby attenuating NO-dependent sweating. Supporting this notion, oxidative stress is associated with a diminished sweating response to exogenous acetylcholine (Hoeldtke et al. 2011) .
In a study conducted in response to reports of diminished NO-dependent cutaneous vasodilatation and sweating during high-intensity exercise (Fujii et al. 2014b) , we demonstrated an oxidative stress-mediated reduction in NO-dependent cutaneous vasodilatation during high (ß71%V O 2 peak ) but not moderate-intensity exercise (ß52%V O 2 peak ) in the heat (35°C; Meade et al. 2015) . However, it is still unknown whether the sweating response is affected in a similar way. Thus, the purpose of the present study was to determine whether oxidative stress influences local sweat production during high-intensity exercise performed in the heat (35°C, 20% relative humidity) and, if so, whether this effect is mediated through diminished NO bioavailability. We hypothesized that local administration of the antioxidant ascorbate (a non-selective antioxidant) would augment NO-dependent sweating during high-but not moderate-intensity exercise in the heat.
Methods
Ethical approval. The experimental protocol was approved by the University of Ottawa Health Sciences Ethics Board (reference H01-14-01) and was in accordance with the Declaration of Helsinki, except for registration in a database. Written and informed consent was obtained from all volunteers before their participation.
Participants. Eleven healthy, habitually active (2-4 days per week of structured physical activity, ࣙ30 min in duration) young men (24 ± 4 years) participated in this study. All participants were free of cardiovascular, metabolic or respiratory disease. Furthermore, participants had no history of autonomic or skin disorders and were non-smoking and not taking any prescribed or over-the-counter medications. Participant characteristics (means ± SD) were as follows: height, 1.75 ± 0.06 m; body mass, 79 ± 10 kg; body surface area, 1.9 ± 0.1 m 2 ; body fat percentage, 14 ± 5%; andV O 2 peak , 45 ± 7 ml O 2 kg −1 min −1 .
Experimental procedures. The general protocol for this experiment has been reported previously (Meade et al. 2015) . However, we have briefly summarized the procedures below. Participants volunteered for one screening and two experimental sessions. All participants abstained from prescribed and over-the-counter medications and vitamin supplements (including vitamins C and E) for a minimum of 48 h before each session, as well as from alcohol, caffeine and heavy exercise for ࣙ24 h before each session, and did not consume food 2 h before each session. Participants reported to each session well hydrated, ensured by the consumption of 500 ml of water the night before and 2 h before the session and confirmed upon arrival using urine specific gravity. During the screening session, anthropometric data andV O 2 peak were determined, the detailed procedures for which are reported elsewhere (Meade et al. 2015) . Upon arrival on the day of the experimental sessions, participants provided a urine sample before a measurement of nude body mass to ensure euhydration (urine specific gravity <1.020; American College of Sports Medicine et al. 2007) . Thereafter, participants rested in a semi-recumbent position in a thermoneutral room (25°C) while four microdialysis fibres were inserted into the dermal layer of skin on the dorsal side of the left forearm. The microdialysis fibres were then perfused with lactated Ringer solution at a rate of 4 µl min −1 via a perfusion pump (model 400; CMA, Microdialysis, Solna, Sweden) for ß60 min to allow for the resolution of the local hyperaemic response. Participants then entered a thermally controlled chamber (Can-Trol Environmental Systems Limited, Markham, ON, Canada) regulated to 35°C and 20% relative humidity and rested quietly on a semi-recumbent cycle ergometer (Corival; Lode B.V., Groningen, The Netherlands). The microdialysis probes were then perfused for ß60 min before and during the experimental protocol at a rate of 4 µl min methyl ester (L-NAME; Sigma-Aldrich), a non-selective NO synthase inhibitor; or (iv) a combination of 10 mM ascorbate and 10 mM L-NAME (Ascorbate + L-NAME). Ascorbate acts an antioxidant by scavenging ROS (e.g. superoxide) and may also improve NO production through the stabilization of tetrahydrobiopterin, an oxidative stress-sensitive cofactor of NO synthase (Mortensen & Lykkesfeldt, 2014) . For examples of studies using cutaneous ascorbate administration (as well as L-NAME) via microdialysis, please see our previous report (Meade et al. 2015) . Approximately 120 min was allowed between the placement of the microdialysis fibres and the start of baseline measurements to ensure that any local trauma associated with insertion of the needle and/or microdialysis fibre had subsided (Hodges et al. 2009 ).
After 10 min of baseline data collection, participants performed two successive 30 min bouts of semi-recumbent cycling, with the first and second exercise bouts followed by a 20 and 40 min recovery period, respectively. This protocol was performed in a counterbalanced manner on two separate days, with the only difference between sessions being the intensity of exercise (quantified as the absolute rate of metabolic heat production to ensure a similar thermal drive for whole-body sweating; Gagnon et al. 2013; Meade & Kenny, 2017) , as follows: (i) moderate intensity, with a rate of metabolic heat production of 500 W (equivalent to 52 ± 6%V O 2 peak ); and (ii) high intensity, with a rate of metabolic heat production of 700 W (equivalent to 71 ± 5%V O 2 peak ).
Measurements. Local forearm sweat rate was measured using the ventilated capsule technique, with capsules placed directly over the centre of each microdialysis membrane and attached to the skin using adhesive rings and topical skin glue (Collodion HV; Mavidon Medical Products, Lake Worth, FL, USA). Dry compressed air was passed through each capsule at a constant flow rate, and the content of the effluent air was measured using a capacitance hygrometer (model HMT333; Vaisala, Helsinki, Finland). Sweat rate was calculated every 5 s using the water of the effluent air multiplied by flow rate and normalized for the skin surface area under the capsule (in milligrams per minute per square centimetre).
A paediatric thermocouple probe (Mon-a-therm; Mallinckrodt Medical, St Louis, MO, USA) was used for the continuous measurement of oesophageal temperature. Mean skin temperature was calculated using six skin sites weighted to the regional proportions (Hardy & Dubois, 1938) as follows: upper back, 21%; chest, 21%; biceps, 19%; quadriceps, 9.5%; hamstring, 9.5%; and front calf, 20%. All temperature data were collected using a data acquisition module at a sampling rate of 15 s and simultaneously displayed and recorded in spreadsheet format on a personal computer with LabVIEW software (version 7.0; National Instruments, Austin, TX, USA).
Systolic and diastolic pressures were monitored before and at 5 min intervals during the experimental protocol via manual auscultation with a validated mercury column sphygmomanometer (Baumanometer Standby Model; W.A. Baum Co., Copiague, NY, USA) and used to calculate mean arterial pressure (diastolic pressure + one-third pulse pressure). Heart rate was recorded continuously and stored every 15 s using a Polar coded WearLink and transmitter, Polar RS400 interface and Polar Trainer 5 software (Polar Electro, Kempele, Finland).
Metabolic rate was calculated from measurements of oxygen uptake (using electrochemical gas analysers, AMETEK model S-3A/1 and CD3A; Applied Electrochemistry, Bastrop, TX, USA) and respiratory exchange ratio obtained every 30 s. Metabolic heat production was subsequently calculated as metabolic rate minus external work .
A hand-held total solids refractometer was used to assess urine specific gravity (Reichert TS 400 total solids refractometer; Reichert Inc., Depew, NY, USA) Data analysis. Baseline resting values were obtained by averaging measurements performed over the first 5 min of the 10 min baseline period. Local sweat rate at each treatment site as well as core and skin temperatures and heart rate data were averaged over the final 5 min of each exercise bout. Furthermore, blood pressure data were presented as an average of the two measurements taken over this interval.
Statistical analysis. Local sweat rate at each treatment site in each of the conditions was compared at baseline and at the end of each exercise bout with a three-way ANOVA, with the repeated factors of treatment (four levels: Control, Ascorbate, L-NAME and Ascorbate + L-NAME), time (three levels: baseline, exercise 1 and exercise 2) and intensity (two levels: moderate and high). Post hoc analysis was carried out using two-tailed Student's paired t tests adjusted for multiple comparisons using the Holm-Bonferroni procedure when necessary. For all analysis, the level of significance was set at P ࣘ 0.05. All values are reported as means ± SD. All statistical analyses were completed using the software package SPSS 24.0 for Windows (IBM, Armonk, NY, USA). Data related to body temperatures, cardiovascular responses and body fluid status for this experiment have already been reported (Meade et al. 2015) and are briefly summarized in the results.
Results
Sweating response. No differences in sweat rate were observed between treatment sites during baseline resting in the moderate-intensity conditions. However, sweat rate was attenuated at L-NAME (all P ࣘ 0.02) and Ascorbate + L-NAME (all P ࣘ 0.01) but not Ascorbate sites (all P ࣙ 0.25) relative to the Control site during both exercise bouts (Fig. 1) . In the high-intensity conditions, sweat rate was similar between treatment sites during baseline resting and both exercise bouts (all P ࣙ 0.09; Fig. 2 ). Control site sweat rate at baseline was similar between conditions (P = 0.74) but elevated in the high-(exercise 1, 1.48 ± 0.50 mg min −1 cm −2 ; exercise 2, 1.47 ± 0.58 mg min −1 cm −2 ) relative to the moderate-intensity conditions (exercise 1, 1.21 ± 0.39 mg min −1 cm −2 ; exercise 2, 1.28 ± 0.49 mg min −1 cm −2 ) during exercise (both P ࣘ 0.05).
Fluid status, body temperature and cardiovascular responses. Results for all variables related to fluid status, body temperatures and cardiovascular responses have been reported elsewhere (Meade et al. 2015) . Participants reported to the laboratory well hydrated, with urine specific gravities of 1.010 ± 0.008 and 1.011 ± 0.008 in the moderate-and high-intensity conditions, respectively. No pretrial differences in body mass (moderate intensity, 79 ± 10 kg; high intensity, 80 ± 11 kg) were observed. . Local sweat rate (n = 11) during the two successive exercise bouts (separated by a 20 min recovery period) in the moderate-intensity conditions [fixed rate of metabolic heat production of 500 W; equivalent to 52 ± 6% peak oxygen uptake (V O2peak )] Throughout the exercise protocol, four skin sites were continuously perfused via intradermal microdialysis with the following solutions: (i) lactated Ringer solution (Control); (ii) 10 mM ascorbate, an antioxidant; (iii) 10 mM N G -nitro-Larginine methyl ester (L-NAME) to inhibit nitric oxide synthase activity; or (iv) a combination of 10 mM ascorbate and 10 mM L-NAME (Ascorbate + L-NAME). Values are shown as means + SD. * Significantly different from Control (P < 0.05). Owing to technical difficulties, local sweat rate data was not collected at the L-NAME and Ascorbate + L-NAME sites for one participant.
However, body mass was reduced to a greater extent in the high-(−2.7 ± 0.5%) relative to moderate-intensity conditions (−1.8 ± 0.9%).
The body temperature and cardiovascular responses to exercise are summarized in Table 1 . In the high-relative to the moderate-intensity conditions, higher oesophageal temperatures were measured during both the first and second exercise bouts, and in both exercise intensity conditions the response in the second exercise bout was greater than in the first. In contrast, no differences in mean skin temperature were observed between conditions. Both mean arterial pressure and heart rate were greater in the high-relative to moderate-intensity exercise conditions in both exercise bouts. Furthermore, heart rate was elevated in the second exercise bout compared with the first in both conditions.
Discussion
In contrast to our hypothesis, local administration of ascorbate did not modulate sweating during high-intensity exercise. Thus, although we previously reported that NO-dependent cutaneous vasodilatation was sensitive to oxidative stress during intense exercise in the heat (Meade et al. 2015) , the same cannot be said for the local forearm sweating response. Fujii et al. (2014b) were the first to demonstrate reduced NO-dependent cutaneous vasodilatation and sweating Throughout the exercise protocol, four skin sites were continuously perfused via intradermal microdialysis with the following solutions: (i) lactated Ringer solution (Control); (ii) 10 mM ascorbate; (iii) 10 mM L-NAME; or (iv) a combination of 10 mM ascorbate and 10 mM L-NAME (Ascorbate + L-NAME). Values are shown as means + SD. Moderate intensity 89 ± 8 9 7 ± 8 * 95 ± 8 * High intensity 91 ± 7 104 ± 9 * † 102 ± 9 * † Heart rate (beats min −1 )
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Moderate intensity 71 ± 10 130 ± 19 * 135 ± 20 * ‡ High intensity 70 ± 12 153 ± 13 * † 161 ± 12 * ‡ † Presented values are means ± SD. Moderate-intensity exercise was performed at a fixed rate of metabolic heat production of 500 W. High-intensity exercise was performed at a fixed rate of metabolic heat production of 700 W. Oesophageal and mean skin temperatures and heart rate responses represent an average of the final 5 min of the corresponding period. Mean arterial pressure values represent an average of two consecutive measurements taken over the final 10 min of the corresponding time period. * P < 0.05 versus rest; † P < 0.05 versus moderate-intensity conditions; ‡ P < 0.05 exercise 1 versus exercise 2. Data are reproduced from Meade et al. (2015) , with permission.
during intense exercise in the heat. NO bioavailability can be impaired by oxidative stress (Radi et al. 1991; Mortensen & Lykkesfeldt, 2014) , which is elevated after high-intensity (but not moderate-intensity) exercise (Goto et al. 2003) , especially when performed in the heat (Sureda et al. 2015) . Thus, we proposed that the mechanism(s) mediating the responses observed by Fujii et al. (2014b) are likely to have stemmed from increased oxidative stress during high-intensity exercise. Indeed, in a follow-up study we demonstrated that local administration of ascorbate (a non-selective antioxidant) augmented the cutaneous vasodilatory response to high-intensity exercise, but not when administered during concurrent NO synthase inhibition (Meade et al. 2015) . In the present report, however, neither the separate nor combined administration of ascorbate and L-NAME influenced sweat rate in the high-intensity conditions (Fig. 2) , despite the clear contribution of NO to sweating in the moderate-intensity conditions (Fig. 1) . The reason(s) underlying the disparate findings for the influence of ROS on NO-dependent cutaneous vasodilatation (Meade et al. 2015) and sweating (present study) during intense exercise are currently unknown, but might result from differences in the precise role of NO in mediating these responses. Local administration of the NO donor sodium nitroprusside elicits cutaneous vasodilatation (Fujii et al. 2014a,b; Meade et al. 2015) but does not directly modulate sweat rate (Fujii et al. 2014b ). Sweat production is primarily induced via muscarinic stimulation of the sweat gland by acetylcholine released from cholinergic nerves (Shibasaki & Crandall, 2010) . The current view is that NO plays a synergistic role in this response such that it acts to augment cholinergic sweating (Fujii et al. 2014b) . It remains unclear, however, whether NO can augment sweat rate across increasing levels of cholinergic stimulation. Lee & Mack (2006) reported that NO contributed to the sweating response induced by intradermal administration of low doses of the cholinergic agonist methacholine (0.033-243 mM methacholine), whereas Fujii et al. (2014a) observed no contribution at comparatively higher doses (1-2000 mM). In the context of whole-body heat stress, these findings suggest that NO might contribute to the sweating response only at moderate levels of thermal drive and therefore cholinergic stimulation, lending support to the idea that the diminished NO-dependent sweating during high-intensity exercise occurs independent of ROS. It is important to note, however, that the level of sweating induced by high doses of methacholine (ß0.5 mg min −1 cm −2 at 2000 mM methacholine; Fujii et al. 2014a ) is considerably lower than those seen in the present study during exercise (1.2-1.4 mg min −1 cm −2 ), suggesting that mechanisms acting apart from or in conjunction with cholinergic activation, potentially those associated with elevated skin temperature, might augment sweating during exercise.
Considerations. We were unable to determine directly whether the high-intensity exercise bouts we used resulted in marked increases in ROS accumulation in comparison to the moderate-intensity conditions, because direct indices of oxidative stress were not evaluated. However, Goto et al. (2003) observed increases in oxidative stress markers after exercise performed at 75 but not 50% V O 2 peak ; exercise intensities that are comparable to the high (ß71%V O 2 peak ) and moderate conditions (ß52%V O 2 peak ) used in the present study, respectively. Furthermore, Sureda et al. (2015) demonstrated greater elevations in oxidative stress after intense exercise (75-85%V O 2 peak ) in a hot environment (ß32°C) compared with a cooler one (ß12°C). In addition, two exercise bouts were used in the present study, resulting in a greater total exercise time and, presumably, greater ROS accumulation in comparison to the aforementioned studies. An accumulation of ROS during the high but not moderate exercise bouts is supported by our previous observations of augmented NO-dependent cutaneous vasodilatation during local administration of ascorbate (Meade et al. 2015) . It is therefore likely that the high-intensity exercise bouts in the present study resulted in marked oxidative stress, whereas comparatively lower levels of ROS accumulation occurred in the moderate conditions.
It is important to note that the present findings might not represent the effects of systemic and/or chronic ascorbate administration (e.g. oral vitamin C supplementation) on the regulation of sweating during heat exposure. Previous studies have, in fact, suggested that ascorbate facilities heat acclimatization (Kotze et al. 1977) and improves heat tolerance (Hindson, 1968; Hindson & Worsley, 1969) . The underpinning mechanisms, however, are not well understood and require further scrutiny.
Conclusion
We showed that sweat rate is not influenced by oxidative stress associated with an accumulation in ascorbatesensitive ROS during high-intensity exercise performed in the heat. Future studies are required to provide better definition of the role of NO in sweating during exercise and to determine other modulators of this response.
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